Company
TwoStep Therapeutics
Developing tumor-targeted therapies with broad applicability across solid tumors
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
TwoStep Therapeutics is developing a pipeline built around a versatile peptide that selectively binds multiple tumor-associated targets—a unique feature that enables the delivery of diverse payloads across a wide range of solid tumor types.
Funding snapshot
- Total raised
- $62.5MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $62.5M2026-09
Funding rounds
- Series A
- $62.5M2026-09, Company stated
Loading relationship preview